{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:29:52Z","timestamp":1791876592404,"version":"4.3.4"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T00:00:00Z","timestamp":1603497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T00:00:00Z","timestamp":1603497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007195","name":"Universit\u00e0 degli Studi di Napoli Federico II","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007195","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Mycosis fungoides (MF) represents the most common type of cutaneous lymphoma. In the majority of patients, the disease has a slow evolution and a protracted course; however, a subset of patients shows poor oncologic outcomes. Unfortunately, there are no reliable prognostic markers for MF, and the currently available treatments are only effective in a minority of patients. This study aimed to evaluate the expression and clinical significance of PARP-1 and CAF-1\/p60 in MF. Sixty-four MF representatives of the different stages of disease were assessed by immunohistochemistry for PARP-1 and CAF-1\/p60. The association of PARP-1 and CAF-1\/p60 with the MF stage and outcome was assessed by using Fisher\u2019s exact test and Kaplan-Meier survival analysis with the Log-rank test; a <jats:italic>p<\/jats:italic> value &lt;\u20090.05 was considered significant. PARP-1 was overexpressed in 57.9% of MF and was significantly associated with a MF stage &gt; II (<jats:italic>p<\/jats:italic>\u2009=\u20090.034) but not with the risk of death (<jats:italic>p<\/jats:italic>\u2009=\u20090.237). CAF-1\/p60 was overexpressed in 26.8% of MF and was significantly associated with decreased overall survival (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) but not with the MF stage (<jats:italic>p<\/jats:italic>\u2009=\u20091). A significant association was found between PARP-1 overexpression and CAF-1\/p60 overexpression (<jats:italic>p<\/jats:italic>\u2009=\u20090.0025). Simultaneous overexpression of PARP-1 and CAF-1\/p60 was significantly associated with decreased overall survival (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), although less strongly than CAF-1\/p60 alone (<jats:italic>\u03c7<\/jats:italic><jats:sup>2<\/jats:sup>\u2009=\u200914.916 vs 21.729, respectively). In MF, PARP-1 is overexpressed in advanced stages, while CAF-1\/p60 is overexpressed in the cases with shorter overall survival, appearing as a significant prognostic marker. A role for PARP-1 inhibitors and anti-CAF-1\/p60 targeted therapy may be reasonably hypothesized in MF.<\/jats:p>","DOI":"10.1007\/s00428-020-02952-z","type":"journal-article","created":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T11:02:24Z","timestamp":1603537344000},"page":"961-968","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Role of chromatin assembly factor-1\/p60 and poly [ADP-ribose] polymerase 1 in mycosis fungoides"],"prefix":"10.1007","volume":"478","author":[{"given":"Massimo","family":"Mascolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Travaglino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Varricchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Sabattini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Agostinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Bertuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonello","family":"Baldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Pileri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Picardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Pane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Staibano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,24]]},"reference":[{"key":"2952_CR1","doi-asserted-by":"publisher","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","volume":"105","author":"R Willemze","year":"2005","unstructured":"Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, Ralfkiaer E, Chimenti S, Diaz-Perez JL, Duncan LM, Grange F, Harris NL, Kempf W, Kerl H, Kurrer M, Knobler R, Pimpinelli N, Sander C, Santucci M, Sterry W, Vermeer MH, Wechsler J, Whittaker S, Meijer CJ (2005) WHO-EORTC classification for cutaneous lymphomas. Blood 105:3768\u20133785. https:\/\/doi.org\/10.1182\/blood-2004-09-3502","journal-title":"Blood"},{"key":"2952_CR2","doi-asserted-by":"publisher","unstructured":"Swerdlow SH et al. (2017) WHO classification of tumors of haematopoietic and lymphoid tissues. Lyon, France. World Health Organization Calssification of Tumors of Haematopoietic and Lymphoid Tissue. doi:https:\/\/doi.org\/10.1017\/CBO9781107415324.004","DOI":"10.1017\/CBO9781107415324.004"},{"key":"2952_CR3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ejca.2017.02.027","volume":"77","author":"F Trautinger","year":"2017","unstructured":"Trautinger F, Eder J, Assaf C, Bagot M, Cozzio A, Dummer R, Gniadecki R, Klemke CD, Ortiz-Romero PL, Papadavid E, Pimpinelli N, Quaglino P, Ranki A, Scarisbrick J, Stadler R, V\u00e4kev\u00e4 L, Vermeer MH, Whittaker S, Willemze R, Knobler R (2017) European organisation for research and treatment of cancer consensus recommendations for the treatment of mycosis fungoides\/S\u00e9zary syndrome - update 2017. Eur J Cancer 77:57\u201374","journal-title":"Eur J Cancer"},{"issue":"11","key":"2952_CR4","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1001\/jamadermatol.2013.5526","volume":"149","author":"K Korgavkar","year":"2013","unstructured":"Korgavkar K, Xiong M, Weinstock M (2013) Changing incidence trends of cutaneous T-cell lymphoma. JAMA Dermatol 149(11):1295\u20131299","journal-title":"JAMA Dermatol"},{"issue":"3","key":"2952_CR5","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.jaad.2017.04.1137","volume":"77","author":"C Su","year":"2017","unstructured":"Su C, Nguyen KA, Bai HX et al (2017) Racial disparity in mycosis fungoides: an analysis of 4495 cases from the US National Cancer Database. J Am Acad Dermatol 77(3):497\u2013502 e2","journal-title":"J Am Acad Dermatol"},{"key":"2952_CR6","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/j.0736-8046.2004.21500.x","volume":"21","author":"R Fink-Puches","year":"2004","unstructured":"Fink-Puches R, Chott A, Ardigo M, Simonitsch I, Ferrara G, Kerl H, Cerroni L (2004) The spectrum of cutaneous lymphomas in patients less than 20 years of age. Pediatr Dermatol 21:525\u2013533. https:\/\/doi.org\/10.1111\/j.0736-8046.2004.21500.x","journal-title":"Pediatr Dermatol"},{"issue":"4","key":"2952_CR7","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.mpdhp.2016.04.004","volume":"22","author":"P Virmani","year":"2016","unstructured":"Virmani P, Myskowski PL, Pulitzer M (2016) Unusual variants of mycosis fungoides. Diagn Histopathol (Oxf) 22(4):142\u2013151","journal-title":"Diagn Histopathol (Oxf)"},{"issue":"2","key":"2952_CR8","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1159\/000479822","volume":"4","author":"G Fabbrocini","year":"2018","unstructured":"Fabbrocini G, Mazzella C, Cantelli M, Baldo A, Russo D, de Rosa G, Monfrecola G (2018) Reflectance confocal microscopy as new diagnostic tool in folliculotropic mycosis fungoides. Skin Appendage Disord 4(2):118\u2013121","journal-title":"Skin Appendage Disord"},{"issue":"5","key":"2952_CR9","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1111\/jdv.14614","volume":"32","author":"M Mascolo","year":"2018","unstructured":"Mascolo M, Romano MF, Ilardi G, Romano S, Baldo A, Scalvenzi M, Argenziano G, Merolla F, Russo D, Varricchio S, Pagliuca F, Russo M, Ciancia G, de Rosa G, Staibano S (2018) Expression of FK506-binding protein 51 (FKBP51) in mycosis fungoides. J Eur Acad Dermatol Venereol 32(5):735\u2013744","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"2952_CR10","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1111\/bjd.12909","volume":"170","author":"JJ Scarisbrick","year":"2014","unstructured":"Scarisbrick JJ, Kim YH, Whittaker SJ, Wood GS, Vermeer MH, Prince HM, Quaglino P (2014) Prognostic factors, prognostic indices and staging in mycosis fungoides and S\u00e9zary syndrome: where are we now? Br J Dermatol 170(6):1226\u20131236","journal-title":"Br J Dermatol"},{"issue":"7","key":"2952_CR11","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1182\/blood-2011-08-376319","volume":"119","author":"MF Benner","year":"2012","unstructured":"Benner MF, Jansen PM, Vermeer MH, Willemze R (2012) Prognostic factors in transformed mycosis fungoides: a retrospective analysis of 100 cases. Blood. 119(7):1643\u20131649","journal-title":"Blood."},{"issue":"1","key":"2952_CR12","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.hoc.2018.09.001","volume":"33","author":"C Larocca","year":"2019","unstructured":"Larocca C, Kupper T (2019) Mycosis fungoides and S\u00e9zary syndrome: an update. Hematol Oncol Clin North Am 33(1):103\u2013120","journal-title":"Hematol Oncol Clin North Am"},{"issue":"12","key":"2952_CR13","doi-asserted-by":"publisher","first-page":"E491","DOI":"10.1002\/ajh.24564","volume":"91","author":"W Hanel","year":"2016","unstructured":"Hanel W, Briski R, Ross CW, Anderson TF, Kaminski MS, Hristov AC, Wilcox RA (2016) A retrospective comparative outcome analysis following systemic therapy in mycosis fungoides and Sezary syndrome. Am J Hematol 91(12):E491\u2013E495","journal-title":"Am J Hematol"},{"issue":"11","key":"2952_CR14","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1002\/ajh.25224","volume":"93","author":"RA Wilcox","year":"2018","unstructured":"Wilcox RA (2018) Cutaneous B-cell lymphomas: 2019 update on diagnosis, risk stratification, and management. Am J Hematol 93(11):1427\u20131430","journal-title":"Am J Hematol"},{"issue":"1","key":"2952_CR15","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1182\/blood-2014-07-588236","volume":"125","author":"CF Hughes","year":"2015","unstructured":"Hughes CF, Khot A, McCormack C et al (2015) Lack of durable disease control with chemotherapy for mycosis fungoides and S\u00e9zary syndrome: a comparative study of systemic therapy. Blood. 125(1):71\u201381","journal-title":"Blood."},{"issue":"29","key":"2952_CR16","doi-asserted-by":"publisher","first-page":"4492","DOI":"10.1200\/JCO.2010.29.3241","volume":"28","author":"RF Duarte","year":"2010","unstructured":"Duarte RF, Canals C, Onida F, Gabriel IH, Arranz R, Arcese W, Ferrant A, Kobbe G, Narni F, Deliliers GL, Olavarr\u00eda E, Schmitz N, Sureda A (2010) Allogeneic hematopoietic cell transplantation for patients with mycosis fungoides and S\u00e9zary syndrome: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. J Clin Oncol 28(29):4492\u20134499","journal-title":"J Clin Oncol"},{"issue":"6","key":"2952_CR17","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/j.1365-2133.1974.tb12449.x","volume":"91","author":"RS Tan","year":"1974","unstructured":"Tan RS, Butterworth CM, McLaughlin H, Malka S, Samman PD (1974) Mycosis fungoides--a disease of antigen persistence. Br J Dermatol 91(6):607\u2013616","journal-title":"Br J Dermatol"},{"key":"2952_CR18","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1159\/000106410","volume":"35","author":"Y Wohl","year":"2007","unstructured":"Wohl Y, Tur E (2007) Environmental risk factors for mycosis fungoides. Curr Probl Dermatol 35:52\u201364","journal-title":"Curr Probl Dermatol"},{"issue":"4","key":"2952_CR19","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/jid.2013.461","volume":"134","author":"LY McGirt","year":"2014","unstructured":"McGirt LY, Adams CM, Baerenwald DA, Zwerner JP, Zic JA, Eischen CM (2014) miR-223 regulates cell growth and targets proto-oncogenes in mycosis fungoides\/cutaneous T-cell lymphoma. J Invest Dermatol 134(4):1101\u20131107","journal-title":"J Invest Dermatol"},{"issue":"23","key":"2952_CR20","doi-asserted-by":"publisher","first-page":"5830","DOI":"10.1002\/cncr.27627","volume":"118","author":"P Quaglino","year":"2012","unstructured":"Quaglino P, Pimpinelli N, Berti E, Calzavara-Pinton P, Alfonso Lombardo G, Rupoli S, Alaibac M, Bottoni U, Carbone A, Fava P, Fimiani M, Mamusa AM, Titli S, Zinzani PL, Bernengo MG, on behalf of the Gruppo Italiano Linfomi Cutanei (GILC) (2012) Time course, clinical pathways, and long-term hazards risk trends of disease progression in patients with classic mycosis fungoides: a multicenter, retrospective follow-up study from the Italian Group of Cutaneous Lymphomas. Cancer. 118(23):5830\u20135839","journal-title":"Cancer."},{"issue":"7","key":"2952_CR21","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1182\/blood-2017-06-788950","volume":"131","author":"LM Lindahl","year":"2018","unstructured":"Lindahl LM, Besenbacher S, Rittig AH, Celis P, Willerslev-Olsen A, Gjerdrum LMR, Krejsgaard T, Johansen C, Litman T, Woetmann A, Odum N, Iversen L (2018) Prognostic miRNA classifier in early-stage mycosis fungoides: development and validation in a Danish nationwide study. Blood. 131(7):759\u2013770","journal-title":"Blood."},{"issue":"440","key":"2952_CR22","doi-asserted-by":"publisher","first-page":"eaar5894","DOI":"10.1126\/scitranslmed.aar5894","volume":"10","author":"A de Masson","year":"2018","unstructured":"de Masson A, O\u2019Malley JT, Elco CP et al (2018) High-throughput sequencing of the T cell receptor \u03b2 gene identifies aggressive early-stage mycosis fungoides. Sci Transl Med 10(440):eaar5894","journal-title":"Sci Transl Med"},{"issue":"12","key":"2952_CR23","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1080\/10428194.2018.1452218","volume":"59","author":"U Wehkamp","year":"2018","unstructured":"Wehkamp U, Weichenthal M, Egberts F, Schwarz T, Klapper W, Oschlies I (2018) Clinically defined subgroups of mycosis fungoides display differing histopathological features at initial biopsy. Leuk Lymphoma 59(12):2871\u20132879","journal-title":"Leuk Lymphoma"},{"issue":"32","key":"2952_CR24","doi-asserted-by":"publisher","first-page":"3766","DOI":"10.1200\/JCO.2015.61.7142","volume":"33","author":"JJ Scarisbrick","year":"2015","unstructured":"Scarisbrick JJ, Prince HM, Vermeer MH, Quaglino P, Horwitz S, Porcu P, Stadler R, Wood GS, Beylot-Barry M, Pham-Ledard A, Foss F, Girardi M, Bagot M, Michel L, Battistella M, Guitart J, Kuzel TM, Martinez-Escala ME, Estrach T, Papadavid E, Antoniou C, Rigopoulos D, Nikolaou V, Sugaya M, Miyagaki T, Gniadecki R, Sanches JA, Cury-Martins J, Miyashiro D, Servitje O, Muniesa C, Berti E, Onida F, Corti L, Hodak E, Amitay-Laish I, Ortiz-Romero PL, Rodr\u00edguez-Peralto JL, Knobler R, Porkert S, Bauer W, Pimpinelli N, Grandi V, Cowan R, Rook A, Kim E, Pileri A, Patrizi A, Pujol RM, Wong H, Tyler K, Stranzenbach R, Querfeld C, Fava P, Maule M, Willemze R, Evison F, Morris S, Twigger R, Talpur R, Kim J, Ognibene G, Li S, Tavallaee M, Hoppe RT, Duvic M, Whittaker SJ, Kim YH (2015) Cutaneous lymphoma international consortium study of outcome in advanced stages of mycosis fungoides and S\u00e9zary syndrome: effect of specific prognostic markers on survival and development of a prognostic model. J Clin Oncol 33(32):3766\u20133773","journal-title":"J Clin Oncol"},{"issue":"2","key":"2952_CR25","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/exd.13477","volume":"27","author":"D Lemchak","year":"2018","unstructured":"Lemchak D, Banerjee S, Digambar SS, Hood BL, Conrads TP, Jedrych J, Geskin L, Akilov OE (2018) Therapeutic and prognostic significance of PARP-1 in advanced mycosis fungoides and Sezary syndrome. Exp Dermatol 27(2):188\u2013190","journal-title":"Exp Dermatol"},{"issue":"8","key":"2952_CR26","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1002\/bies.20085","volume":"26","author":"JC Am\u00e9","year":"2004","unstructured":"Am\u00e9 JC, Spenlehauer C, de Murcia G (2004) The PARP superfamily. Bioessays. 26(8):882\u2013893","journal-title":"Bioessays."},{"key":"2952_CR27","doi-asserted-by":"crossref","unstructured":"Bryant HE, Schultz N, Thomas HD, Parker KM, Flower D, Lopez E, Kyle S, Meuth M, Curtin NJ, Helleday T (2005) Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase [published correction appears in Nature. 2007 May 17;447(7142):346]. Nature. 434(7035):913\u2013917","DOI":"10.1038\/nature03443"},{"issue":"7035","key":"2952_CR28","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nature03445","volume":"434","author":"H Farmer","year":"2005","unstructured":"Farmer H, McCabe N, Lord CJ, Tutt ANJ, Johnson DA, Richardson TB, Santarosa M, Dillon KJ, Hickson I, Knights C, Martin NMB, Jackson SP, Smith GCM, Ashworth A (2005) Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature. 434(7035):917\u2013921","journal-title":"Nature."},{"issue":"12","key":"2952_CR29","doi-asserted-by":"publisher","first-page":"e82872","DOI":"10.1371\/journal.pone.0082872","volume":"8","author":"L Yang","year":"2013","unstructured":"Yang L, Huang K, Li X, du M, Kang X, Luo X, Gao L, Wang C, Zhang Y, Zhang C, Tong Q, Huang K, Zhang F, Huang D (2013) Identification of poly(ADP-ribose) polymerase-1 as a cell cycle regulator through modulating Sp1 mediated transcription in human hepatoma cells. PLoS One 8(12):e82872","journal-title":"PLoS One"},{"issue":"4","key":"2952_CR30","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nsmb.2258","volume":"19","author":"A Ray Chaudhuri","year":"2012","unstructured":"Ray Chaudhuri A, Hashimoto Y, Herrador R, Neelsen KJ, Fachinetti D, Bermejo R, Cocito A, Costanzo V, Lopes M (2012) Topoisomerase I poisoning results in PARP-mediated replication fork reversal. Nat Struct Mol Biol 19(4):417\u2013423","journal-title":"Nat Struct Mol Biol"},{"issue":"Pt 6","key":"2952_CR31","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1242\/jcs.01080","volume":"117","author":"M Rouleau","year":"2004","unstructured":"Rouleau M, Aubin RA, Poirier GG (2004) Poly(ADP-ribosyl)ated chromatin domains: access granted. J Cell Sci 117(Pt 6):815\u2013825","journal-title":"J Cell Sci"},{"issue":"8","key":"2952_CR32","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.bbagrm.2015.05.009","volume":"1849","author":"A Volk","year":"2015","unstructured":"Volk A, Crispino JD (2015) The role of the chromatin assembly complex (CAF-1) and its p60 subunit (CHAF1b) in homeostasis and disease. Biochim Biophys Acta 1849(8):979\u2013986","journal-title":"Biochim Biophys Acta"},{"issue":"7","key":"2952_CR33","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/ncpendmet0531","volume":"3","author":"SE Ozanne","year":"2007","unstructured":"Ozanne SE, Const\u00e2ncia M (2007) Mechanisms of disease: the developmental origins of disease and the role of the epigenotype. Nat Clin Pract Endocrinol Metab 3(7):539\u2013546","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"12","key":"2952_CR34","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1111\/j.1432-1033.2004.04162.x","volume":"271","author":"AE Ehrenhofer-Murray","year":"2004","unstructured":"Ehrenhofer-Murray AE (2004) Chromatin dynamics at DNA replication, transcription and repair. Eur J Biochem 271(12):2335\u20132349","journal-title":"Eur J Biochem"},{"issue":"1","key":"2952_CR35","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0092-8674(00)81326-4","volume":"87","author":"A Verreault","year":"1996","unstructured":"Verreault A, Kaufman PD, Kobayashi R, Stillman B (1996) Nucleosome assembly by a complex of CAF-1 and acetylated histones H3\/H4. Cell. 87(1):95\u2013104","journal-title":"Cell."},{"issue":"2","key":"2952_CR36","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.dnarep.2008.11.007","volume":"8","author":"Q Zhu","year":"2009","unstructured":"Zhu Q, Wani G, Arab HH, El-Mahdy MA, Ray A, Wani AA (2009) Chromatin restoration following nucleotide excision repair involves the incorporation of ubiquitinated H2A at damaged genomic sites. DNA Repair (Amst) 8(2):262\u2013273","journal-title":"DNA Repair (Amst)"},{"issue":"1","key":"2952_CR37","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0092-8674(03)01064-X","volume":"116","author":"H Tagami","year":"2004","unstructured":"Tagami H, Ray-Gallet D, Almouzni G, Nakatani Y (2004) Histone H3.1 and H3.3 complexes mediate nucleosome assembly pathways dependent or independent of DNA synthesis. Cell. 116(1):51\u201361","journal-title":"Cell."},{"issue":"12","key":"2952_CR38","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.tplants.2007.10.002","volume":"12","author":"E Ramirez-Parra","year":"2007","unstructured":"Ramirez-Parra E, Gutierrez C (2007) The many faces of chromatin assembly factor 1. Trends Plant Sci 12(12):570\u2013576","journal-title":"Trends Plant Sci"},{"issue":"6","key":"2952_CR39","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/S0092-8674(00)80164-6","volume":"86","author":"PHL Gaillard","year":"1996","unstructured":"Gaillard PHL, Martini EM, Kaufman PD, Stillman B, Moustacchi E, Almouzni G (1996) Chromatin assembly coupled to DNA repair: a new role for chromatin assembly factor I. Cell. 86(6):887\u2013896","journal-title":"Cell."},{"issue":"1\u20132","key":"2952_CR40","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.mrfmmm.2006.05.039","volume":"618","author":"JG Linger","year":"2007","unstructured":"Linger JG, Tyler JK (2007) Chromatin disassembly and reassembly during DNA repair. Mutat Res 618(1\u20132):52\u201364","journal-title":"Mutat Res"},{"issue":"17","key":"2952_CR41","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1007\/s00018-004-4176-y","volume":"61","author":"A Verger","year":"2004","unstructured":"Verger A, Crossley M (2004) Chromatin modifiers in transcription and DNA repair. Cell Mol Life Sci 61(17):2154\u20132162","journal-title":"Cell Mol Life Sci"},{"issue":"7","key":"2952_CR42","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1158\/0008-5472.CAN-03-2893","volume":"64","author":"SE Polo","year":"2004","unstructured":"Polo SE, Theocharis SE, Klijanienko J, Savignoni A, Asselain B, Vielh P, Almouzni G (2004) Chromatin assembly factor-1, a marker of clinical value to distinguish quiescent from proliferating cells. Cancer Res 64(7):2371\u20132381","journal-title":"Cancer Res"},{"issue":"5","key":"2952_CR43","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1111\/j.1365-2559.2010.03681.x","volume":"57","author":"SE Polo","year":"2010","unstructured":"Polo SE, Theocharis SE, Grandin L, Gambotti L, Antoni G, Savignoni A, Asselain B, Patsouris E, Almouzni G (2010) Clinical significance and prognostic value of chromatin assembly factor-1 overexpression in human solid tumours. Histopathology. 57(5):716\u2013724","journal-title":"Histopathology."},{"issue":"1","key":"2952_CR44","doi-asserted-by":"publisher","first-page":"17","DOI":"10.14639\/0392-100X-867","volume":"37","author":"M Mesolella","year":"2017","unstructured":"Mesolella M, Iorio B, Landi M, Cimmino M, Ilardi G, Iengo M, Mascolo M (2017) Overexpression of chromatin assembly factor-1\/p60 predicts biological behaviour of laryngeal carcinomas. L\u2019espressivit\u00e0 della proteina CAF-1 p60 come fattore prognostico nei carcinomi laringei. Acta Otorhinolaryngol Ital 37(1):17\u201324","journal-title":"Acta Otorhinolaryngol Ital"},{"issue":"9","key":"2952_CR45","doi-asserted-by":"publisher","first-page":"11044","DOI":"10.3390\/ijms130911044","volume":"13","author":"M Mascolo","year":"2012","unstructured":"Mascolo M, Ilardi G, Merolla F, Russo D, Vecchione ML, de Rosa G, Staibano S (2012) Tissue microarray-based evaluation of chromatin assembly factor-1 (CAF-1)\/p60 as tumour prognostic marker. Int J Mol Sci 13(9):11044\u201311062","journal-title":"Int J Mol Sci"},{"issue":"6","key":"2952_CR46","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1111\/j.1365-2559.2012.04313.x","volume":"61","author":"M Mascolo","year":"2012","unstructured":"Mascolo M, Ilardi G, Romano MF, Celetti A, Siano M, Romano S, Luise C, Merolla F, Rocco A, Vecchione ML, de Rosa G, Staibano S (2012) Overexpression of chromatin assembly factor-1 p60, poly(ADP-ribose) polymerase 1 and nestin predicts metastasizing behaviour of oral cancer. Histopathology. 61(6):1089\u20131105","journal-title":"Histopathology."},{"issue":"1","key":"2952_CR47","first-page":"13","volume":"25","author":"S Staibano","year":"2011","unstructured":"Staibano S, Mascolo M, Rocco A, Lo Muzio L, Ilardi G, Siano M, Pannone G, Vecchione ML, Nugnes L, Califano L, Zamparese R, Bufo P, de Rosa G (2011) The proliferation marker chromatin assembly factor-1 is of clinical value in predicting the biological behaviour of salivary gland tumours. Oncol Rep 25(1):13\u201322","journal-title":"Oncol Rep"},{"key":"2952_CR48","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/1471-2407-10-63","volume":"10","author":"M Mascolo","year":"2010","unstructured":"Mascolo M, Vecchione ML, Ilardi G, Scalvenzi M, Molea G, di Benedetto M, Nugnes L, Siano M, de Rosa G, Staibano S (2010) Overexpression of chromatin assembly factor-1\/p60 helps to predict the prognosis of melanoma patients. BMC Cancer 10:63","journal-title":"BMC Cancer"},{"issue":"5","key":"2952_CR49","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1111\/j.1365-2559.2009.03266.x","volume":"54","author":"S Staibano","year":"2009","unstructured":"Staibano S, Mascolo M, Mancini FP, Kisslinger A, Salvatore G, di Benedetto M, Chieffi P, Altieri V, Prezioso D, Ilardi G, de Rosa G, Tramontano D (2009) Overexpression of chromatin assembly factor-1 (CAF-1) p60 is predictive of adverse behaviour of prostatic cancer. Histopathology. 54(5):580\u2013589","journal-title":"Histopathology."},{"issue":"8","key":"2952_CR50","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1177\/1947601910383418","volume":"1","author":"V Ossovskaya","year":"2010","unstructured":"Ossovskaya V, Koo IC, Kaldjian EP, Alvares C, Sherman BM (2010) Upregulation of Poly (ADP-Ribose) Polymerase-1 (PARP1) in Triple-Negative Breast Cancer and Other Primary Human Tumor Types. Genes Cancer 1(8):812\u2013821","journal-title":"Genes Cancer"},{"issue":"10","key":"2952_CR51","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.3390\/cancers11101582","volume":"11","author":"F Morra","year":"2019","unstructured":"Morra F, Merolla F, Picardi I et al (2019) CAF-1 subunits levels suggest combined treatments with PARP-inhibitors and ionizing radiation in advanced HNSCC. Cancers (Basel). 11(10):1582","journal-title":"Cancers (Basel)."}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-020-02952-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-020-02952-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-020-02952-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,23]],"date-time":"2021-10-23T19:17:33Z","timestamp":1635016653000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-020-02952-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,24]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["2952"],"URL":"https:\/\/doi.org\/10.1007\/s00428-020-02952-z","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,24]]},"assertion":[{"value":"30 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was performed according to the guidelines of the Institutional Ethics Committee, which, in agreement with the Italian law, with reference to the topics of the current research, do not ask for the Ethical Committee approval, and, according to the Declaration of Helsinki, requires, for studies based only on retrospective analyses on routine archival formalin-fixed, paraffin-embedded tissue a written informed consent from the living patient, following the indication of Italian DLgs no. 196\/03 (Codex on Privacy) at the time of surgery.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}